drugset / Trial / NCT00638651

Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal

NCT00638651

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of tattoo removal using topical imiquimod, 5% cream in conjunction with the 1064nm Nd:YAG laser. This procedure for tattoo removal will be compared to a laser removal alone.

Timeline

Start
2008-02
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Imiquimod Other / unclassified 5 % Topical

Indications

No indication recorded.